Earnings ·
CVS Health Corporation reported second quarter 2026 results with total revenues increasing 7.3% year-over-year to…
CVSCVS HEALTH Corp
CVS Health Corporation reported second quarter 2026 results with total revenues increasing 7.3% year-over-year to $106.1 billion. GAAP diluted earnings per share rose to $2.31 from $0.80 in the prior year, while adjusted EPS reached $2.58 compared to $1.81. The company raised its full-year 2026 guidance, increasing the projected GAAP diluted EPS range to $6.84–$7.04 from $6.24–$6.44 and adjusting the cash flow from operations target upward to at least $11.5 billion. CVS Health operates in the healthcare services industry, providing pharmacy benefits management, retail pharmacy services, and health insurance products.